People with non-valvular atrial fibrillation (a common type of heart murmur) who are using the anti-clotting drug Pradaxa to reduce their risk of stroke may be putting themselves at risk for more problems. The following information has been released by the Food and Drug Administration (FDA) in the midst of ongoing investigations into the many reports of Pradaxa-related deaths:
- The FDA urges you to call for immediate help if you experience any of the following symptoms: heavily bleeding gums, frequently occurring nosebleed, unusually heavy menstrual or vaginal bleeding, uncontrolled severe bleeding, discolored urine (pink or brown), tarlike stools that are red or black, unexplained bruises which grow in size, coughing up or vomiting blood or blood clots (can sometimes resemble coffee grounds).
- The FDA maintains that Pradaxa can be beneficial when used correctly, and urges patients to read and follow the instructions on the label.
- It is important that you not stop taking Pradaxa without first talking to your doctor. Cutting Pradaxa out without speaking with your healthcare professional will put you at high risk of a stroke.
- The FDA is still working to figure out if reports of serious bleeding in Pradaxa patients are, in fact, happening more frequently than initially expected.
- Lastly, it is important to report any unusual bleeding or concerns about side effects to your doctor, as well as to the FDA’s MedWatch program at 1-800-332-1088.
If you’ve read the FDA’s Pradaxa findings and still have questions, feel free to call the Pradaxa injury lawyers at Gray and White Law by calling toll free 1-888-450-4456.